The Senior Care Pharmacist

Early June 2020 Article Release

COVID-19— Face Mask Effectiveness, Hand Sanitizer Shortages, and Rapid Medication Therapy Trials

The COVID-19 pandemic is a rapidly evolving phenomenon that presents serious practical challenges and complex clinical considerations for health care workers, health care administrators, and policy formulators. The Senior Care Pharmacist carries periodic updates addressing matters relevant to pharmacotherapeutics and pharmacy practice as these relate to the care of older people in the time of the pandemic. The brief news items that are provided here are not intended to be substitutes for a careful and comprehensive consideration of the issues involved, but rather, they serve to provide initial awareness of concepts and to stimulate more complete situational analysis.


IN THIS ISSUE

May 2020 | Volume 35 | Number 5

Pharmacists: Safeguards Between Older People and Their Psychotropic Medications

Now, more than ever, older people need pharmacists to protect them from medication-related problems inherent to psychotropic drugs. It is clear that, because of their specific training and technical knowledge in the area of pharmacotherapy, pharmacists have a logical place in any multidisciplinary context where drug treatment is prescribed—and always will be.

On the Pharmacy Radar: COVID-19 and Older People

The COVID-19 pandemic presents many medical and social issues for older people. This article offers a range of information arising from related areas that have impact on the safety and efficacy of drug therapy for older people.

Psychotropic Medicine Stewardship: A Critical Role for Pharmacists in Long-Term Care Facilities

There are many opportunities for pharmacists to contribute to the better use of anxiolytic and sedative-hypnotic drugs, typically overprescribed and maintained for longer than recommended. Our research group has conducted a series of in-depth qualitative analyses that have deepened our understanding of the impact of organizational culture in long-term care facilities on the use of psychotropic medications.

Anxiety Disorders in Older People

FAnxiety disorders may be the most common mental disorder among the older population. Experts estimate its prevalence to be between 1.2% and 15% in community samples and 1% and 28% in medical settings. These patients manifest the symptoms of anxiety, and they are also at risk for increased disability, decreased health-related quality of life, and possibly mild cognitive impairment. For this reason, it is important for pharmacists to understand the challenges in assessing anxiety and the treatment options that are safe and effective in the older adult population. Additionally, pharmacists must be able to communicate well with these patients despite their tendency to perseverate and fixate.

Changes in Psychotropic Prescribing for Patients With Dementia, 2014-2016: Potential Implications for Pharmacists

Behavioral and psychological symptoms of dementia, also known as neuropsychiatric symptoms of dementia, often cause significant distress for patients and caregivers. Statistically significant increases in the prescribing of anticonvulsants and sedatives in physician visits from 2014 to 2016 suggest the possibility that these agents are being used to combat behavioral and psychological symptoms in patients with dementia. Further research is required to assess the rationale, efficacy, and safety of these uses.

Geriatric Pharmacotherapy Case Series: Overactive Bladder

The use of anticholinergics is often the go-to solution for urinary incontinence and over-active bladder; however, it is important to realize that an overrelaxed bladder can cause postvoid urinary residual that can lead to increased symptoms—rather than improved symptoms—for any patient. The newer class of beta-3 agonists also relax the bladder, as do anticholinergic agents, and should be used with caution with persons with urinary retention. The additional impact of anticholinergic medications on cognition and functional status can make successful toileting very challenging.

Drug-Induced Kidney Disease Associated With Selected Antibiotics

Structural and functional degeneration of the kidneys occur as the human body ages, making older people especially susceptible to the consequences of acute kidney injury. The use of nephrotoxic agents, combined with the increased incidence of acute kidney injury, makes geriatric patients prone to the development of drug-induced kidney disease. This article discusses the mechanisms of drug induced kidney disease with regard to vancomycin, daptomycin, and ceftaroline to provide insight as to their safety profiles with regard to the elderly. A clear understanding of this topic will aid clinicians in selecting drug therapy and may lead to shortened hospital stays, lower hospital costs, and improved outcomes of critically ill older people.

Impact of Pharmacist Interventions in an Ambulatory Geriatric Care Clinic: The IMPACC Study

In this study, the inclusion of a pharmacist in an interdisciplinary team in an ambulatory geriatric-care clinic was associated with a positive impact on care by substantially increasing the number of drug related problems detected in older patients. The pharmacist has an added value to the interdisciplinary team in an ambulatory geriatric care clinic. By detecting these problems, the pharmacist can suggest appropriate changes to patients’ drug therapy, and, therefore, they may improve patient health, quality of life, and reduce adverse drug reactions.

How Will COVID-19 Affect Long-Term Care?

The decision of the Centers for Medicare & Medicaid Services to suspend routine surveys in favor of focused inspections targeted at infection control is the first signal that long-term care will be at the epicenter of federal oversight.

READ THE JOURNAL

The Senior Care Pharmacist® is the official peer-reviewed journal of the American Society of Consultant Pharmacists (ASCP). It is the only journal dedicated exclusively to the medication therapy needs of older adults. ASCP members receive The Senior Care Pharmacist® as a member benefit. All articles (2004 to present) are free online for members.




Nonmembers can access online abstracts to journal articles. Full articles are available for $35.00 each.


Content can be tailored and customized to fit your marketing and promotional needs and can be delivered via print or electronic format. For more information, contact:
Patti Thompson
Production & Design Manager, ASCP
pthompson@ascp.com


Chris Alderman, B Pharm, PhD, FASCP, FSHP, BCGP, BCPP
Editor-in-Chief
calderman@ascp.com

Demetra Antimisiaris, PharmD, BCGP, FASCP
Associate Editor
tscp@ascp.com

Justin Turner, BPharm, MClinPharm, Ph.D.
Associate Editor
tscp@ascp.com

Timothy W. Meyers Ph.D., RN
Statistical Consultant
tscp@ascp.com

Eleanor Tipton
Creative Editor
etipton@ascp.com

Marlene Z. Bloom
Managing Editor
mbloom@ascp.com

Patti Thompson
Production & Design Manager
pthompson@ascp.com


ASCP
1240 N Pitt St., 3rd Floor
Alexandria, VA 22314
tscp@ascp.com

Click here to read The Consultant Pharmacist archive.



Individual Subscriptions
Individuals who want to receive access to The Senior Care Pharmacist but are prohibited from joining the Society, can now subscribe to the journal. Subscription options include print and online combo, print-only, and online-only.
Subscribe as an Individual

Institutions and Libraries
Libraries or other institutions may receive unlimited access to the journal online for $310 annually. Pay-per-view, individual articles ordered from the online version only, are $35 per article. Subscription rates are in U.S. dollars and are subject to change.
Subscribe as an Institution

ASCP
1240 N Pitt St, Suite 300, Alexandria, VA 22314
© 2016-2018 ASCP | Contact Us | Privacy Policy
ASCP Foundation | BCGP